Natanja Oosterom

516 total citations
17 papers, 361 citations indexed

About

Natanja Oosterom is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Natanja Oosterom has authored 17 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 10 papers in Pediatrics, Perinatology and Child Health and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Natanja Oosterom's work include Acute Lymphoblastic Leukemia research (10 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Oral health in cancer treatment (6 papers). Natanja Oosterom is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Oral health in cancer treatment (6 papers). Natanja Oosterom collaborates with scholars based in Netherlands, United States and Spain. Natanja Oosterom's co-authors include Róbert de Jonge, Marry M. van den Heuvel‐Eibrink, Sandra G. Heil, Rob Pieters, Leslie Carstensen Floren, H.E. Westerveld, Olle ten Cate, Elixabet López-López, Wim J. E. Tissing and Tom F.W. Wolfs and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Natanja Oosterom

17 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natanja Oosterom Netherlands 13 149 99 78 66 59 17 361
Jessica M. Valdez United States 10 66 0.4× 102 1.0× 97 1.2× 37 0.6× 62 1.1× 15 370
Kumar Srivastava United States 10 117 0.8× 183 1.8× 156 2.0× 37 0.6× 51 0.9× 19 391
Ida Hed Myrberg Sweden 14 155 1.0× 115 1.2× 74 0.9× 39 0.6× 70 1.2× 35 454
Jui‐Der Liou Taiwan 14 44 0.3× 267 2.7× 36 0.5× 94 1.4× 64 1.1× 31 621
Shlomi Sagi Israel 17 139 0.9× 169 1.7× 69 0.9× 192 2.9× 55 0.9× 49 844
Eralp Başer Türkiye 14 83 0.6× 112 1.1× 72 0.9× 170 2.6× 53 0.9× 44 523
Giuseppe Ettore Italy 13 85 0.6× 91 0.9× 62 0.8× 93 1.4× 42 0.7× 61 612
Annette Sander Germany 12 307 2.1× 95 1.0× 155 2.0× 88 1.3× 159 2.7× 37 736
Simone Martins de Castro Brazil 13 39 0.3× 110 1.1× 48 0.6× 33 0.5× 80 1.4× 43 476
Nader Kim El‐Mallawany United States 16 116 0.8× 92 0.9× 341 4.4× 77 1.2× 47 0.8× 52 577

Countries citing papers authored by Natanja Oosterom

Since Specialization
Citations

This map shows the geographic impact of Natanja Oosterom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natanja Oosterom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natanja Oosterom more than expected).

Fields of papers citing papers by Natanja Oosterom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natanja Oosterom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natanja Oosterom. The network helps show where Natanja Oosterom may publish in the future.

Co-authorship network of co-authors of Natanja Oosterom

This figure shows the co-authorship network connecting the top 25 collaborators of Natanja Oosterom. A scholar is included among the top collaborators of Natanja Oosterom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natanja Oosterom. Natanja Oosterom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Oosterom, Natanja, Saskia L. Gooskens, Lindsay A. Renfro, et al.. (2023). Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy. Journal of Clinical Oncology. 41(26). 4247–4256. 1 indexed citations
2.
Oosterom, Natanja, Donato Gemmati, Rachael Windsor, et al.. (2021). Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 161. 103312–103312. 12 indexed citations
3.
López-López, Elixabet, et al.. (2021). Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies. Cancers. 13(11). 2837–2837. 43 indexed citations
4.
Zelst, Bertrand D. van, et al.. (2020). Global DNA (hydroxy)methylation is stable over time under several storage conditions and temperatures. Epigenetics. 16(1). 45–53. 22 indexed citations
5.
Oosterom, Natanja, Marta Fiocco, Inge M. van der Sluis, et al.. (2020). The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia. BMC Cancer. 20(1). 940–940. 4 indexed citations
6.
Driehuis, Else, Natanja Oosterom, Sandra G. Heil, et al.. (2020). Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia. PLoS ONE. 15(5). e0231588–e0231588. 25 indexed citations
7.
Oosterom, Natanja, et al.. (2020). Clinical Characteristics of Invasive Fungal Infections in Pediatric Oncology Patients With Solid Tumors. Journal of Pediatric Hematology/Oncology. 43(3). e408–e413. 5 indexed citations
8.
Oosterom, Natanja, Róbert de Jonge, Desirée E.C. Smith, et al.. (2019). Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia. PLoS ONE. 14(9). e0221591–e0221591. 13 indexed citations
9.
Oosterom, Natanja, et al.. (2019). The effect of leucovorin rescue therapy on methotrexate-induced oral mucositis in the treatment of paediatric ALL: A systematic review. Critical Reviews in Oncology/Hematology. 142. 1–8. 24 indexed citations
10.
11.
Oosterom, Natanja, Oliver Zolk, Saskia M.F. Pluijm, et al.. (2018). The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. Pharmacogenetics and Genomics. 28(10). 223–229. 21 indexed citations
12.
Oosterom, Natanja, Rob Pieters, Róbert de Jonge, et al.. (2018). Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. PLoS ONE. 13(7). e0199574–e0199574. 19 indexed citations
13.
Oosterom, Natanja, Sandra G. Heil, Róbert de Jonge, et al.. (2018). A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. Supportive Care in Cancer. 27(1). 183–190. 23 indexed citations
14.
Oosterom, Natanja, Leslie Carstensen Floren, Olle ten Cate, & H.E. Westerveld. (2018). A review of interprofessional training wards: Enhancing student learning and patient outcomes. Medical Teacher. 41(5). 547–554. 58 indexed citations
15.
Oosterom, Natanja, Sandra G. Heil, Róbert de Jonge, et al.. (2017). a Decrease in Vitamin D Levels Is Associated with Methotrexate-Induced Oral Mucositis in Children with Acute Lymphoblastic Leukemia. Blood. 130. 2573–2573. 1 indexed citations
16.
Gutiérrez-Camino, Ángela, Natanja Oosterom, Elixabet López-López, et al.. (2017). The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia. Pharmacogenetics and Genomics. 27(8). 303–306. 33 indexed citations
17.
Oosterom, Natanja, et al.. (2015). Neuro-Imaging Findings in Infants with Congenital Cytomegalovirus Infection: Relation to Trimester of Infection. Neonatology. 107(4). 289–296. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica M. Valdez Breakdown of academic impact, for papers by Kumar Srivastava Breakdown of academic impact, for papers by Ida Hed Myrberg Breakdown of academic impact, for papers by Jui‐Der Liou Breakdown of academic impact, for papers by Shlomi Sagi Breakdown of academic impact, for papers by Eralp Başer Breakdown of academic impact, for papers by Giuseppe Ettore Breakdown of academic impact, for papers by Annette Sander Breakdown of academic impact, for papers by Simone Martins de Castro Breakdown of academic impact, for papers by Nader Kim El‐Mallawany
Rankless by CCL
2026